4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001144204-16-104313
Options or other derivatives
- President and CEO acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| CARUSO JAMES V President and CEO | 2016-05-12 | Grant or award · Stock option (right to buy) | +200,000 | $0.01 | $2,000 | 237,500 | D |
Loading xslF345X03/v440762_4.xml…